{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:54:47Z","timestamp":1790790887474,"version":"4.1.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Neurosurgical Institute","award":["11000025T000003319495-3"],"award-info":[{"award-number":["11000025T000003319495-3"]}]},{"name":"Natural Science Foundation","award":["82401480"],"award-info":[{"award-number":["82401480"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00415-025-13546-7","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:30:16Z","timestamp":1764570616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cerebrospinal fluid biomarkers for diagnosis of Parkinson\u2019s disease: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"272","author":[{"given":"Siming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"13546_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2016 Neurology Collaborators (2019) Global, Regional, and National Burden of Neurological Disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X.","DOI":"10.1016\/S1474-4422(18)30499-X"},{"issue":"5","key":"13546_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"issue":"12","key":"13546_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"10","key":"13546_CR4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D (2018) Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 33(10):1601\u20131608. https:\/\/doi.org\/10.1002\/mds.27362","journal-title":"Mov Disord"},{"issue":"1","key":"13546_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13054-021-03698-z","volume":"25","author":"CA Santacruz","year":"2021","unstructured":"Santacruz CA, Vincent J-L, Bader A, Rinc\u00f3n-Guti\u00e9rrez LA, Dominguez-Curell C, Communi D, Taccone FS (2021) Association of cerebrospinal fluid protein biomarkers with outcomes in patients with traumatic and non-traumatic acute brain injury: systematic review of the literature. Crit Care 25(1):278. https:\/\/doi.org\/10.1186\/s13054-021-03698-z","journal-title":"Crit Care"},{"issue":"5","key":"13546_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/mds.29360","volume":"38","author":"JM den Heijer","year":"2023","unstructured":"den Heijer JM, Cullen VC, Pereira DR, Yavuz Y, de Kam ML, Grievink HW, Moerland M, Leymarie N, Khatri K, Sollomoni I, Spitalny L, Dungeon L, Hilt DC, Justman C, Lansbury P, Groeneveld GJ (2023) A biomarker study in patients with GBA1-Parkinson\u2019s disease and healthy controls. Mov Disord 38(5):783\u2013795. https:\/\/doi.org\/10.1002\/mds.29360","journal-title":"Mov Disord"},{"issue":"4","key":"13546_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153564","volume":"11","author":"N Kruse","year":"2016","unstructured":"Kruse N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, Vanderstichele H, El-Agnaf OM, Mollenhauer B (2016) A first tetraplex assay for the simultaneous quantification of total \u03b1-synuclein, tau, \u03b2-amyloid42 and DJ-1 in human cerebrospinal fluid. PLoS ONE 11(4):e0153564. https:\/\/doi.org\/10.1371\/journal.pone.0153564","journal-title":"PLoS ONE"},{"issue":"4","key":"13546_CR8","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1212\/WNL.0000000000201418","volume":"100","author":"L Oftedal","year":"2023","unstructured":"Oftedal L, Maple-Gr\u00f8dem J, Dalen I, Tysnes O-B, Pedersen KF, Alves G, Lange J (2023) Association of CSF glucocerebrosidase activity with the risk of incident dementia in patients with Parkinson disease. Neurology 100(4):e388\u2013e395. https:\/\/doi.org\/10.1212\/WNL.0000000000201418","journal-title":"Neurology"},{"issue":"21","key":"13546_CR9","doi-asserted-by":"publisher","first-page":"e2417","DOI":"10.1212\/WNL.0000000000201199","volume":"99","author":"N Majbour","year":"2022","unstructured":"Majbour N, Aasly J, Abdi I, Ghanem S, Erskine D, van de Berg W, El-Agnaf O (2022) Disease-associated \u03b1-synuclein aggregates as biomarkers of Parkinson disease clinical stage. Neurology 99(21):e2417\u2013e2427. https:\/\/doi.org\/10.1212\/WNL.0000000000201199","journal-title":"Neurology"},{"issue":"11","key":"13546_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206536","volume":"13","author":"MCT Dos Santos","year":"2018","unstructured":"Dos Santos MCT, Scheller D, Schulte C, Mesa IR, Colman P, Bujac SR, Bell R, Berteau C, Perez LT, Lachmann I, Berg D, Maetzler W, da Nogueira Costa A (2018) Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson\u2019s disease diagnosis. PLoS ONE 13(11):e0206536. https:\/\/doi.org\/10.1371\/journal.pone.0206536","journal-title":"PLoS ONE"},{"key":"13546_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neulet.2017.12.023","volume":"665","author":"C An","year":"2018","unstructured":"An C, Pu X, Xiao W, Zhang H (2018) Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson\u2019s disease. Neurosci Lett 665:236\u2013239. https:\/\/doi.org\/10.1016\/j.neulet.2017.12.023","journal-title":"Neurosci Lett"},{"key":"13546_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.959261","volume":"16","author":"Y Liu","year":"2022","unstructured":"Liu Y, Dou K, Xue L, Li X, Xie A (2022) Neurofilament light as a biomarker for motor decline in Parkinson\u2019s disease. Front Neurosci 16:959261. https:\/\/doi.org\/10.3389\/fnins.2022.959261","journal-title":"Front Neurosci"},{"issue":"1","key":"13546_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD, Antelmi E, Mammana A, Hughson AG, Calandra-Buonaura G, Ladogana A, Plazzi G, Cortelli P, Caughey B, Parchi P (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140(1):49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13546_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jnc.14569","volume":"149","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer B, Bowman FD, Drake D, Duong J, Blennow K, El-Agnaf O, Shaw LM, Masucci J, Taylor P, Umek RM, Dunty JM, Smith CL, Stoops E, Vanderstichele H, Schmid AW, Moniatte M, Zhang J, Kruse N, Lashuel HA, Teunissen C, Schubert T, Dave KD, Hutten SJ, Zetterberg H (2019) Antibody-based methods for the measurement of \u03b1-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study. J Neurochem 149(1):126\u2013138. https:\/\/doi.org\/10.1111\/jnc.14569","journal-title":"J Neurochem"},{"issue":"1","key":"13546_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00330-x","volume":"8","author":"L Bl\u00f6meke","year":"2022","unstructured":"Bl\u00f6meke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamg\u00fcney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach O, Chen-Plotkin A, Willbold D (2022) Quantitative detection of \u03b1-synuclein and tau oligomers and other aggregates by digital single particle counting. NPJ Parkinsons Dis 8(1):68. https:\/\/doi.org\/10.1038\/s41531-022-00330-x","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"13546_CR16","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00702-018-1893-1","volume":"125","author":"T Schirinzi","year":"2018","unstructured":"Schirinzi T, Sancesario GM, Di Lazzaro G, Scalise S, Colona VL, Imbriani P, Mercuri NB, Bernardini S, Lang AE, Pisani A (2018) Clinical value of CSF amyloid-beta-42 and tau proteins in progressive supranuclear palsy. J Neural Transm 125(9):1373\u20131379. https:\/\/doi.org\/10.1007\/s00702-018-1893-1","journal-title":"J Neural Transm"},{"key":"13546_CR17","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"13546_CR18","first-page":"165","volume":"39","author":"SE Daniel","year":"1993","unstructured":"Daniel SE, Lees AJ (1993) Parkinson\u2019s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39:165\u2013172","journal-title":"J Neural Transm Suppl"},{"issue":"12","key":"13546_CR19","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"9","key":"13546_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, D\u00fcrr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670\u2013676. https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15","journal-title":"Neurology"},{"key":"13546_CR21","unstructured":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/35445419\/. Accessed 03 Aug 2024"},{"issue":"1","key":"13546_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/wnl.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1\u20139. https:\/\/doi.org\/10.1212\/wnl.47.1.1","journal-title":"Neurology"},{"key":"13546_CR23","doi-asserted-by":"publisher","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2017) Movement Disorder Society-endorsed PSP Study Group. Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria. Mov Disord 32(6):853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","DOI":"10.1002\/mds.26987"},{"issue":"12","key":"13546_CR24","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies. Neurology 65(12):1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"key":"13546_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2288-6-31","volume":"6","author":"J Zamora","year":"2006","unstructured":"Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31. https:\/\/doi.org\/10.1186\/1471-2288-6-31","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"13546_CR26","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58(10):982\u2013990. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.02.022","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"13546_CR27","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2015.16.6.1188","volume":"16","author":"J Lee","year":"2015","unstructured":"Lee J, Kim KW, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-Part II. Statistical methods of meta-analysis. Korean J Radiol 16(6):1188. https:\/\/doi.org\/10.3348\/kjr.2015.16.6.1188","journal-title":"Korean J Radiol"},{"issue":"6","key":"13546_CR28","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1177\/0962280216669182","volume":"27","author":"VN Nyaga","year":"2018","unstructured":"Nyaga VN, Aerts M, Arbyn M (2018) ANOVA model for network meta-analysis of diagnostic test accuracy data. Stat Methods Med Res 27(6):1766\u20131784. https:\/\/doi.org\/10.1177\/0962280216669182","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"13546_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H (2018) Quantifying publication bias in meta-analysis. Biometrics 74(3):785\u2013794. https:\/\/doi.org\/10.1111\/biom.12817","journal-title":"Biometrics"},{"issue":"5","key":"13546_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","volume":"66","author":"JL Bro\u017cek","year":"2011","unstructured":"Bro\u017cek JL, Akl EA, Compalati E, Kreis J, Terracciano L, Fiocchi A, Ueffing E, Andrews J, Alonso-Coello P, Meerpohl JJ, Lang DM, Jaeschke R, Williams JW, Phillips B, Lethaby A, Bossuyt P, Glasziou P, Helfand M, Watine J, Afilalo M, Welch V, Montedori A, Abraha I, Horvath AR, Bousquet J, Guyatt GH, Sch\u00fcnemann HJ, GRADE Working Group (2011) Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy 66(5):588\u2013595. https:\/\/doi.org\/10.1111\/j.1398-9995.2010.02530.x","journal-title":"Allergy"},{"issue":"1","key":"13546_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0339-1","volume":"10","author":"L Gaetani","year":"2018","unstructured":"Gaetani L, H\u00f6glund K, Parnetti L, Pujol-Calderon F, Becker B, Eusebi P, Sarchielli P, Calabresi P, Di Filippo M, Zetterberg H, Blennow K (2018) A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimers Res Ther 10(1):8. https:\/\/doi.org\/10.1186\/s13195-018-0339-1","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"13546_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/acn3.51280","volume":"8","author":"CD Orr\u00f9","year":"2021","unstructured":"Orr\u00f9 CD, Ma TC, Hughson AG, Groveman BR, Srivastava A, Galasko D, Angers R, Downey P, Crawford K, Hutten SJ, Kang UJ, Caughey B (2021) A rapid \u03b1-synuclein seed assay of Parkinson\u2019s disease CSF panel shows high diagnostic accuracy. Ann Clin Transl Neurol 8(2):374\u2013384. https:\/\/doi.org\/10.1002\/acn3.51280","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"13546_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/mds.29329","volume":"38","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Weber S, Farris CM, Dakna M, Lang E, Wicke T, Ma Y, Starke M, Ebentheuer J, Sixel-D\u00f6ring F, Muntean M-L, Schade S, Trenkwalder C, Soto C, Mollenhauer B (2023) Accurate detection of \u03b1-synuclein seeds in cerebrospinal fluid from isolated rapid eye movement sleep behavior disorder and patients with Parkinson\u2019s disease in the DeNovo Parkinson (DeNoPa) cohort. Mov Disord: Off J Mov Disord Soc 38(4):567\u2013578. https:\/\/doi.org\/10.1002\/mds.29329","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"key":"13546_CR34","unstructured":"Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from lewy body synucleinopathies\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32557811\/. Accessed 18 Aug 2025"},{"issue":"4","key":"13546_CR35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JPD-202141","volume":"10","author":"M von Euler Chelpin","year":"2020","unstructured":"von Euler Chelpin M, S\u00f6derberg L, F\u00e4lting J, M\u00f6ller C, Giorgetti M, Constantinescu R, Blennow K, Zetterberg H, H\u00f6glund K (2020) Alpha-synuclein protofibrils in cerebrospinal fluid: a potential biomarker for Parkinson\u2019s disease. J Parkinsons Dis 10(4):1429\u20131442. https:\/\/doi.org\/10.3233\/JPD-202141","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"13546_CR36","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MTM, Parkkinen L, Green AJE (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3(10):812\u2013818. https:\/\/doi.org\/10.1002\/acn3.338","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"13546_CR37","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s13238-017-0424-4","volume":"8","author":"H Zhao","year":"2017","unstructured":"Zhao H, Zhao J, Hou J, Wang S, Ding Y, Lu B, Wang J (2017) AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson\u2019s disease diagnosis. Protein Cell 8(9):696\u2013700. https:\/\/doi.org\/10.1007\/s13238-017-0424-4","journal-title":"Protein Cell"},{"issue":"5","key":"13546_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant D-E, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C, Parkinson\u2019s Progression Markers Initiative (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"issue":"1","key":"13546_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40478-021-01276-6","volume":"9","author":"K Brockmann","year":"2021","unstructured":"Brockmann K, Quadalti C, Lerche S, Rossi M, Wurster I, Baiardi S, Roeben B, Mammana A, Zimmermann M, Hauser A-K, Deuschle C, Schulte C, Waniek K, Lachmann I, Sj\u00f6din S, Brinkmalm A, Blennow K, Zetterberg H, Gasser T, Parchi P (2021) Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol Commun 9(1):175. https:\/\/doi.org\/10.1186\/s40478-021-01276-6","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"13546_CR40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nan.12524","volume":"45","author":"H Ning","year":"2019","unstructured":"Ning H, Wu Q, Han D, Yao T, Wang J, Lu W, Lv S, Jia Q, Li X (2019) Baseline concentration of misfolded \u03b1-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson\u2019s disease. Neuropathol Appl Neurobiol 45(4):398\u2013409. https:\/\/doi.org\/10.1111\/nan.12524","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"10","key":"13546_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257372","volume":"16","author":"M Bartl","year":"2021","unstructured":"Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B, Parkinson\u2019s Progression Markers Initiative (2021) Biomarkers of neurodegeneration and glial activation validated in Alzheimer\u2019s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson\u2019s disease. PLoS ONE 16(10):e0257372. https:\/\/doi.org\/10.1371\/journal.pone.0257372","journal-title":"PLoS ONE"},{"issue":"10","key":"13546_CR42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K, Swedish BioFINDER study (2017) Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930\u2013937. https:\/\/doi.org\/10.1212\/WNL.0000000000003680","journal-title":"Neurology"},{"issue":"2","key":"13546_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/mds.29284","volume":"38","author":"A Garrido","year":"2023","unstructured":"Garrido A, Fairfoul G, Tolosa E, Marti MJ, Ezquerra M, Green AJE (2023) Brain and cerebrospinal fluid \u03b1-synuclein real-time quaking-induced conversion identifies Lewy body pathology in LRRK2-PD. Mov Disord 38(2):333\u2013338. https:\/\/doi.org\/10.1002\/mds.29284","journal-title":"Mov Disord"},{"issue":"5","key":"13546_CR44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/acn3.51753","volume":"10","author":"LM Chahine","year":"2023","unstructured":"Chahine LM, Beach TG, Adler CH, Hepker M, Kanthasamy A, Appel S, Pritzkow S, Pinho M, Mosovsky S, Serrano GE, Coffey C, Brumm MC, Oliveira LMA, Eberling J, Mollenhauer B, Systemic Synuclein Sampling Study (2023) Central and peripheral \u03b1-synuclein in Parkinson disease detected by seed amplification assay. Ann Clin Transl Neurol 10(5):696\u2013705. https:\/\/doi.org\/10.1002\/acn3.51753","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"13546_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.22311","volume":"69","author":"M Shi","year":"2011","unstructured":"Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69(3):570\u2013580. https:\/\/doi.org\/10.1002\/ana.22311","journal-title":"Ann Neurol"},{"issue":"1","key":"13546_CR46","doi-asserted-by":"publisher","first-page":"16866","DOI":"10.1038\/s41598-018-35376-6","volume":"8","author":"J Youn","year":"2018","unstructured":"Youn J, Lee S-B, Lee HS, Yang HO, Park J, Kim JS, Oh E, Park S, Jang W (2018) Cerebrospinal fluid levels of autophagy-related proteins represent potentially novel biomarkers of early-stage Parkinson\u2019s disease. Sci Rep 8(1):16866. https:\/\/doi.org\/10.1038\/s41598-018-35376-6","journal-title":"Sci Rep"},{"issue":"8","key":"13546_CR47","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/mds.25772","volume":"29","author":"L Parnetti","year":"2014","unstructured":"Parnetti L, Chiasserini D, Persichetti E, Eusebi P, Varghese S, Qureshi MM, Dardis A, Deganuto M, De Carlo C, Castrioto A, Balducci C, Paciotti S, Tambasco N, Bembi B, Bonanni L, Onofrj M, Rossi A, Beccari T, El-Agnaf O, Calabresi P (2014) Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson\u2019s disease. Mov Disord 29(8):1019\u20131027. https:\/\/doi.org\/10.1002\/mds.25772","journal-title":"Mov Disord"},{"issue":"10","key":"13546_CR48","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","volume":"72","author":"DC B\u00e4ckstr\u00f6m","year":"2015","unstructured":"B\u00e4ckstr\u00f6m DC, Eriksson Domell\u00f6f M, Linder J, Olsson B, \u00d6hrfelt A, Trupp M, Zetterberg H, Blennow K, Forsgren L (2015) Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease. JAMA Neurol 72(10):1175\u20131182. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1449","journal-title":"JAMA Neurol"},{"issue":"8","key":"13546_CR49","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/mds.23670","volume":"26","author":"L Parnetti","year":"2011","unstructured":"Parnetti L, Chiasserini D, Bellomo G, Giannandrea D, De Carlo C, Qureshi MM, Ardah MT, Varghese S, Bonanni L, Borroni B, Tambasco N, Eusebi P, Rossi A, Onofrj M, Padovani A, Calabresi P, El-Agnaf O (2011) Cerebrospinal fluid tau\/\u03b1-synuclein ratio in Parkinson\u2019s disease and degenerative dementias. Mov Disord 26(8):1428\u20131435. https:\/\/doi.org\/10.1002\/mds.23670","journal-title":"Mov Disord"},{"issue":"10","key":"13546_CR50","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/mds.27136","volume":"32","author":"L Parnetti","year":"2017","unstructured":"Parnetti L, Paciotti S, Eusebi P, Dardis A, Zampieri S, Chiasserini D, Tasegian A, Tambasco N, Bembi B, Calabresi P, Beccari T (2017) Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in Parkinson\u2019s disease patients. Mov Disord Off J Mov Disord Soc 32(10):1423\u20131431. https:\/\/doi.org\/10.1002\/mds.27136","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"11","key":"13546_CR51","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00415-016-8259-0","volume":"263","author":"F Llorens","year":"2016","unstructured":"Llorens F, Schmitz M, Varges D, Kruse N, Gotzmann N, Gmitterov\u00e1 K, Mollenhauer B, Zerr I (2016) Cerebrospinal \u03b1-synuclein in \u03b1-synuclein aggregation disorders: tau\/\u03b1-synuclein ratio as potential biomarker for dementia with Lewy bodies. J Neurol 263(11):2271\u20132277. https:\/\/doi.org\/10.1007\/s00415-016-8259-0","journal-title":"J Neurol"},{"issue":"9","key":"13546_CR52","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00702-018-1893-1","volume":"125","author":"T Schirinzi","year":"2018","unstructured":"Schirinzi T, Sancesario GM, Di Lazzaro G, Scalise S, Colona VL, Imbriani P, Mercuri NB, Bernardini S, Lang AE, Pisani A (2018) Clinical value of CSF amyloid-beta-42 and tau proteins in progressive supranuclear palsy. J Neural Transm 125(9):1373\u20131379. https:\/\/doi.org\/10.1007\/s00702-018-1893-1","journal-title":"J Neural Transm"},{"key":"13546_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.parkreldis.2022.05.006","volume":"99","author":"Y Compta","year":"2022","unstructured":"Compta Y, Painous C, Soto M, Pulido-Salgado M, Fern\u00e1ndez M, Camara A, S\u00e1nchez V, Bargall\u00f3 N, Caballol N, Pont-Sunyer C, Buongiorno M, Martin N, Basora M, Tio M, Giraldo DM, P\u00e9rez-Soriano A, Zaro I, Mu\u00f1oz E, Mart\u00ed MJ, Valldeoriola F (2022) Combined CSF \u03b1-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: from bedside to bench, and back again. Parkinsonism Relat Disord 99:33\u201341. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.006","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13546_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/acn3.509","volume":"5","author":"Z Yu","year":"2018","unstructured":"Yu Z, Stewart T, Aasly J, Shi M, Zhang J (2018) Combining clinical and biofluid markers for early Parkinson\u2019s disease detection. Ann Clin Transl Neurol 5(1):109\u2013114. https:\/\/doi.org\/10.1002\/acn3.509","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"13546_CR55","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1007\/s00415-021-10778-1","volume":"269","author":"A Sakurai","year":"2022","unstructured":"Sakurai A, Tsunemi T, Ishiguro Y, Okuzumi A, Hatano T, Hattori N (2022) Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus. J Neurol 269(4):2022\u20132029. https:\/\/doi.org\/10.1007\/s00415-021-10778-1","journal-title":"J Neurol"},{"issue":"5","key":"13546_CR56","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neurobiolaging.2006.03.010","volume":"28","author":"WF Abdo","year":"2007","unstructured":"Abdo WF, Bloem BR, Van Geel WJ, Esselink RAJ, Verbeek MM (2007) CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson\u2019s disease. Neurobiol Aging 28(5):742\u2013747. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.03.010","journal-title":"Neurobiol Aging"},{"key":"13546_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00091","volume":"6","author":"MK Herbert","year":"2015","unstructured":"Herbert MK, Aerts MB, Beenes M, Norgren N, Esselink RAJ, Bloem BR, Kuiperij HB, Verbeek MM (2015) CSF neurofilament light chain but not FLT3 ligand discriminates parkinsonian disorders. Front Neurol 6:91. https:\/\/doi.org\/10.3389\/fneur.2015.00091","journal-title":"Front Neurol"},{"issue":"2","key":"13546_CR58","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/mds.27897","volume":"35","author":"LP Oosterveld","year":"2020","unstructured":"Oosterveld LP, Verberk IMW, Majbour NK, El-Agnaf OM, Weinstein HC, Berendse HW, Teunissen CE, van de Berg WDJ (2020) CSF or serum neurofilament light added to \u03b1-synuclein panel discriminates Parkinson\u2019s from controls. Mov Disord 35(2):288\u2013295. https:\/\/doi.org\/10.1002\/mds.27897","journal-title":"Mov Disord"},{"issue":"4","key":"13546_CR59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.parkreldis.2014.01.011","volume":"20","author":"S Mondello","year":"2014","unstructured":"Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A (2014) CSF \u03b1-synuclein and UCH-L1 levels in Parkinson\u2019s disease and atypical parkinsonian disorders. Parkinsonism Relat Disord 20(4):382\u2013387. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.01.011","journal-title":"Parkinsonism Relat Disord"},{"key":"13546_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.parkreldis.2018.10.018","volume":"61","author":"T Schirinzi","year":"2019","unstructured":"Schirinzi T, Sancesario GM, Di Lazzaro G, Biticchi B, Colona VL, Mercuri NB, Bernardini S, Pisani A (2019) CSF \u03b1-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients. Parkinsonism Relat Disord 61:203\u2013206. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13546_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s1353-8020(00)00083-3","volume":"8","author":"B Holmberg","year":"2001","unstructured":"Holmberg B, Johnels B, Ingvarsson P, Eriksson B, Rosengren L (2001) CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of parkinsonian syndromes. Parkinsonism Relat Disord 8(1):23\u201331. https:\/\/doi.org\/10.1016\/s1353-8020(00)00083-3","journal-title":"Parkinsonism Relat Disord"},{"key":"13546_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.717930","volume":"13","author":"S Canaslan","year":"2021","unstructured":"Canaslan S, Schmitz M, Villar-Piqu\u00e9 A, Maass F, Gmitterov\u00e1 K, Varges D, Lingor P, Llorens F, Hermann P, Zerr I (2021) Detection of cerebrospinal fluid neurofilament light chain as a marker for alpha-synucleinopathies. Front Aging Neurosci 13:717930. https:\/\/doi.org\/10.3389\/fnagi.2021.717930","journal-title":"Front Aging Neurosci"},{"issue":"20","key":"13546_CR63","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SaS, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, El-Agnaf OMA (2010) Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75(20):1766\u20131772. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd613b","journal-title":"Neurology"},{"key":"13546_CR64","unstructured":"Development of a biochemical diagnosis of parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid | neurology | JAMA neurology | JAMA network. https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2588684. Accessed 18 Aug 2025"},{"issue":"2","key":"13546_CR65","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","volume":"145","author":"I Poggiolini","year":"2022","unstructured":"Poggiolini I, Gupta V, Lawton M, Lee S, El-Turabi A, Querejeta-Coma A, Trenkwalder C, Sixel-D\u00f6ring F, Foubert-Samier A, Pavy-Le Traon A, Plazzi G, Biscarini F, Montplaisir J, Gagnon J-F, Postuma RB, Antelmi E, Meissner WG, Mollenhauer B, Ben-Shlomo Y, Hu MT, Parkkinen L (2022) Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain 145(2):584\u2013595. https:\/\/doi.org\/10.1093\/brain\/awab431","journal-title":"Brain"},{"key":"13546_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00053","volume":"6","author":"L Parnetti","year":"2014","unstructured":"Parnetti L, Farotti L, Eusebi P, Chiasserini D, De Carlo C, Giannandrea D, Salvadori N, Lisetti V, Tambasco N, Rossi A, Majbour NK, El-Agnaf O, Calabresi P (2014) <article-title update=\"added\">Differential role of CSF alpha-synuclein species, tau, and A\u00ce\u00b242 in Parkinson\u2019s disease. Front Aging Neurosci 6:53. https:\/\/doi.org\/10.3389\/fnagi.2014.00053","journal-title":"Front Aging Neurosci"},{"issue":"7794","key":"13546_CR67","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, Tsai A-L, Shirani H, Nilsson KPR, Low PA, Soto C (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578(7794):273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"issue":"21","key":"13546_CR68","doi-asserted-by":"publisher","first-page":"e2417","DOI":"10.1212\/WNL.0000000000201199","volume":"99","author":"N Majbour","year":"2022","unstructured":"Majbour N, Aasly J, Abdi I, Ghanem S, Erskine D, van de Berg W, El-Agnaf O (2022) Disease-associated \u03b1-synuclein aggregates as biomarkers of Parkinson disease clinical stage. Neurology 99(21):e2417\u2013e2427. https:\/\/doi.org\/10.1212\/WNL.0000000000201199","journal-title":"Neurology"},{"issue":"3","key":"13546_CR69","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain: J Neurol 133(3):713\u2013726. https:\/\/doi.org\/10.1093\/brain\/awq008","journal-title":"Brain: J Neurol"},{"issue":"1","key":"13546_CR70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40035-021-00232-7","volume":"10","author":"X Morat\u00f3","year":"2021","unstructured":"Morat\u00f3 X, Garcia-Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, Borr\u00e0s E, Sabid\u00f3 E, Pet\u00e4j\u00e4-Repo UE, Fern\u00e1ndez-Due\u00f1as V, Ferrer I, Svenningsson P, Ciruela F (2021) Ecto-GPR37: a potential biomarker for Parkinson\u2019s disease. Transl Neurodegener 10(1):8. https:\/\/doi.org\/10.1186\/s40035-021-00232-7","journal-title":"Transl Neurodegener"},{"key":"13546_CR71","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fnagi.2014.00248","volume":"6","author":"JO Aasly","year":"2014","unstructured":"Aasly JO, Johansen KK, Br\u00f8nstad G, War\u00f8 BJ, Majbour NK, Varghese S, Alzahmi F, Paleologou KE, Amer DAM, Al-Hayani A, El-Agnaf OMA (2014) Elevated Levels of Cerebrospinal Fluid \u03b1-Synuclein Oligomers in Healthy Asymptomatic LRRK2 Mutation Carriers. Front Aging Neurosci 6:248. https:\/\/doi.org\/10.3389\/fnagi.2014.00248","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"13546_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206536","volume":"13","author":"MCT Dos Santos","year":"2018","unstructured":"Dos Santos MCT, Scheller D, Schulte C, Mesa IR, Colman P, Bujac SR, Bell R, Berteau C, Perez LT, Lachmann I, Berg D, Maetzler W, da Nogueira Costa A (2018) Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson\u2019s disease diagnosis. PLoS ONE 13(11):e0206536. https:\/\/doi.org\/10.1371\/journal.pone.0206536","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"13546_CR73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000353442","volume":"36","author":"M Nutu","year":"2013","unstructured":"Nutu M, Zetterberg H, Londos E, Minthon L, N\u00e4gga K, Blennow K, Hansson O, Ohrfelt A (2013) Evaluation of the cerebrospinal fluid amyloid-\u03921-42\/amyloid-\u03921-40 ratio measured by Alpha-LISA to distinguish Alzheimer\u2019s disease from other dementia disorders. Dement Geriatr Cogn Disord 36(1\u20132):99\u2013110. https:\/\/doi.org\/10.1159\/000353442","journal-title":"Dement Geriatr Cogn Disord"},{"key":"13546_CR74","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.2147\/NDT.S205550","volume":"15","author":"AK Gupta","year":"2019","unstructured":"Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G (2019) Evaluation of \u03b1-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson\u2019s disease and schizophrenia. Neuropsychiatr Dis Treat 15:2073\u20132085. https:\/\/doi.org\/10.2147\/NDT.S205550","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"10","key":"13546_CR75","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1007\/s00415-024-12647-z","volume":"271","author":"S Katzdobler","year":"2024","unstructured":"Katzdobler S, N\u00fcbling G, Klietz M, Fietzek UM, Palleis C, Bernhardt AM, Wegner F, Huber M, Rogozinski S, Schneider L-S, Spruth EJ, Beyle A, Vogt IR, Brandt M, Hansen N, Glanz W, Brockmann K, Spottke A, Hoffmann DC, Peters O, Priller J, Wiltfang J, D\u00fczel E, Schneider A, Falkenburger B, Klockgether T, Gasser T, Nuscher B, Haass C, H\u00f6glinger G, Levin J (2024) GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA). J Neurol 271(10):6991\u20136999. https:\/\/doi.org\/10.1007\/s00415-024-12647-z","journal-title":"J Neurol"},{"issue":"1","key":"13546_CR76","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo MJ, Orru CD, Concha-Marambio L, Giaisi S, Groveman BR, Farris CM, Holguin B, Hughson AG, LaFontant D-E, Caspell-Garcia C, Coffey CS, Mollon J, Hutten SJ, Merchant K, Heym RG, Soto C, Caughey B, Kang UJ (2021) High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. Acta Neuropathol Commun 9(1):179. https:\/\/doi.org\/10.1186\/s40478-021-01282-8","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"13546_CR77","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00702-019-02137-2","volume":"127","author":"A Bougea","year":"2020","unstructured":"Bougea A, Stefanis L, Emmanouilidou E, Vekrelis K, Kapaki E (2020) High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases. J Neural Transm 127(3):311\u2013322. https:\/\/doi.org\/10.1007\/s00702-019-02137-2","journal-title":"J Neural Transm"},{"issue":"20","key":"13546_CR78","doi-asserted-by":"publisher","first-page":"e2513","DOI":"10.1212\/WNL.0000000000011935","volume":"96","author":"V Donadio","year":"2021","unstructured":"Donadio V, Wang Z, Incensi A, Rizzo G, Fileccia E, Vacchiano V, Capellari S, Magnani M, Scaglione C, Stanzani Maserati M, Avoni P, Liguori R, Zou W (2021) In vivo diagnosis of synucleinopathies: a comparative study of skin biopsy and RT-QuIC. Neurology 96(20):e2513\u2013e2524. https:\/\/doi.org\/10.1212\/WNL.0000000000011935","journal-title":"Neurology"},{"issue":"9","key":"13546_CR79","doi-asserted-by":"publisher","first-page":"e1267","DOI":"10.1212\/WNL.0000000000010404","volume":"95","author":"LM Chahine","year":"2020","unstructured":"Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, Kopil CM, Riley L, Dave KD, Mollenhauer B (2020) In vivo distribution of \u03b1-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology 95(9):e1267\u2013e1284. https:\/\/doi.org\/10.1212\/WNL.0000000000010404","journal-title":"Neurology"},{"issue":"1\u20132","key":"13546_CR80","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jns.2015.10.011","volume":"358","author":"F Llorens","year":"2015","unstructured":"Llorens F, Schmitz M, Gloeckner SF, Kaerst L, Hermann P, Schmidt C, Varges D, Zerr I (2015) Increased albumin CSF\/serum ratio in dementia with Lewy bodies. J Neurol Sci 358(1\u20132):398\u2013403. https:\/\/doi.org\/10.1016\/j.jns.2015.10.011","journal-title":"J Neurol Sci"},{"key":"13546_CR81","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fnagi.2020.00156","volume":"12","author":"E Papu\u0107","year":"2020","unstructured":"Papu\u0107 E, Rejdak K (2020) Increased cerebrospinal fluid S100\u03b2 and NSE reflect neuronal and glial damage in Parkinson\u2019s disease. Front Aging Neurosci 12:156. https:\/\/doi.org\/10.3389\/fnagi.2020.00156","journal-title":"Front Aging Neurosci"},{"key":"13546_CR82","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fnagi.2020.00128","volume":"12","author":"E Papu\u0107","year":"2020","unstructured":"Papu\u0107 E, Rejdak K (2020) Increased CSF NFL in non-demented Parkinson\u2019s disease subjects reflects early white matter damage. Front Aging Neurosci 12:128. https:\/\/doi.org\/10.3389\/fnagi.2020.00128","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"13546_CR83","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12883-020-1608-8","volume":"20","author":"A Santaella","year":"2020","unstructured":"Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, van Gool AJ, Bloem BR, Verbeek MM (2020) INfLammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms. BMC Neurol 20(1):26. https:\/\/doi.org\/10.1186\/s12883-020-1608-8","journal-title":"BMC Neurol"},{"issue":"4","key":"13546_CR84","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/alz.13658","volume":"20","author":"G Bellomo","year":"2024","unstructured":"Bellomo G, Toja A, Paolini Paoletti F, Ma Y, Farris CM, Gaetani L, Salvadori N, Chiasserini D, Wojda\u019aa AL, Concha-Marambio L, Parnetti L (2024) Investigating alpha-synuclein co-pathology in Alzheimer\u2019s disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay. Alzheimers Dement 20(4):2444\u20132452. https:\/\/doi.org\/10.1002\/alz.13658","journal-title":"Alzheimers Dement"},{"issue":"1","key":"13546_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00232-4","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S, Mastrangelo A, Rossi M, Zenesini C, Giannini G, Candelise N, Sambati L, Polischi B, Plazzi G, Capellari S, Cortelli P, Parchi P (2021) Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in Parkinsonisms and related syndromes. NPJ Parkinsons Dis 7(1):93. https:\/\/doi.org\/10.1038\/s41531-021-00232-4","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"13546_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00311-3","volume":"11","author":"M Bongianni","year":"2022","unstructured":"Bongianni M, Catalan M, Perra D, Fontana E, Janes F, Bertolotti C, Sacchetto L, Capaldi S, Tagliapietra M, Polverino P, Tommasini V, Bellavita G, Kachoie EA, Baruca R, Bernardini A, Valente M, Fiorini M, Bronzato E, Tamburin S, Bertolasi L, Brozzetti L, Cecchini MP, Gigli G, Monaco S, Manganotti P, Zanusso G (2022) Olfactory swab sampling optimization for \u03b1-synuclein aggregate detection in patients with Parkinson\u2019s disease. Transl Neurodegener 11(1):37. https:\/\/doi.org\/10.1186\/s40035-022-00311-3","journal-title":"Transl Neurodegener"},{"key":"13546_CR87","doi-asserted-by":"publisher","unstructured":"Nk M, Nn V, Kd van D, Mt A, S V, Lb V, Lp M, S P, B SG, T T, Ce T, Hw B, Wd van de B, Om EA (2016) Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease. Mol. Neurodegener. https:\/\/doi.org\/10.1186\/s13024-016-0072-9.","DOI":"10.1186\/s13024-016-0072-9"},{"issue":"1","key":"13546_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01388-7","volume":"10","author":"S Hall","year":"2022","unstructured":"Hall S, Orr\u00f9 CD, Serrano GE, Galasko D, Hughson AG, Groveman BR, Adler CH, Beach TG, Caughey B, Hansson O (2022) Performance of \u03b1Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun 10(1):90. https:\/\/doi.org\/10.1186\/s40478-022-01388-7","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"13546_CR89","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno S-I, Imamichi-Tatano Y, Kimura H, Kakuta S, Kondo A, Fukuhara T, Li Y, Funayama M, Saiki S, Taniguchi D, Tsunemi T, McIntyre D, G\u00e9rardy J-J, Mittelbronn M, Kruger R, Uchiyama Y, Nukina N, Hattori N (2023) Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 29(6):1448\u20131455. https:\/\/doi.org\/10.1038\/s41591-023-02358-9","journal-title":"Nat Med"},{"issue":"1","key":"13546_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00330-x","volume":"8","author":"L Bl\u00f6meke","year":"2022","unstructured":"Bl\u00f6meke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamg\u00fcney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach O, Chen-Plotkin A, Willbold D (2022) Quantitative detection of \u03b1-synuclein and tau oligomers and other aggregates by digital single particle counting. NPJ Parkinsons Dis 8(1):68. https:\/\/doi.org\/10.1038\/s41531-022-00330-x","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"13546_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B (2018) Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun 6(1):7. https:\/\/doi.org\/10.1186\/s40478-018-0508-2","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"13546_CR92","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/ene.12176","volume":"21","author":"KD van Dijk","year":"2014","unstructured":"van Dijk KD, Bidinosti M, Weiss A, Raijmakers P, Berendse HW, van de Berg WDJ (2014) Reduced \u03b1-synuclein levels in cerebrospinal fluid in Parkinson\u2019s disease are unrelated to clinical and imaging measures of disease severity. Eur J Neurol 21(3):388\u2013394. https:\/\/doi.org\/10.1111\/ene.12176","journal-title":"Eur J Neurol"},{"issue":"12","key":"13546_CR93","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1474-4422(24)00395-8","volume":"23","author":"Y Ma","year":"2024","unstructured":"Ma Y, Farris CM, Weber S, Schade S, Nguyen H, P\u00e9rez-Soriano A, Giraldo DM, Fern\u00e1ndez M, Soto M, C\u00e1mara A, Painous C, Mu\u00f1oz E, Valldeoriola F, Mart\u00ed MJ, Clarimon J, Kallunki P, Ma TC, Alcalay RN, Gomes BF, Blennow K, Zetterberg H, Constantinescu J, Mengel D, Kadam V, Parchi P, Brockmann K, Tropea TF, Siderowf A, Synofzik M, Kang UJ, Compta Y, Svenningsson P, Mollenhauer B, Concha-Marambio L (2024) Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. Lancet Neurol 23(12):1225\u20131237. https:\/\/doi.org\/10.1016\/S1474-4422(24)00395-8","journal-title":"Lancet Neurol"},{"issue":"1","key":"13546_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01175-w","volume":"9","author":"C Bargar","year":"2021","unstructured":"Bargar C, Wang W, Gunzler SA, LeFevre A, Wang Z, Lerner AJ, Singh N, Tatsuoka C, Appleby B, Zhu X, Xu R, Haroutunian V, Zou W-Q, Ma J, Chen SG (2021) Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol Commun 9(1):62. https:\/\/doi.org\/10.1186\/s40478-021-01175-w","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"13546_CR95","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/mds.27001","volume":"32","author":"M Delgado-Alvarado","year":"2017","unstructured":"Delgado-Alvarado M, Gago B, Gorostidi A, Jim\u00e9nez-Urbieta H, Dacosta-Aguayo R, Navalpotro-G\u00f3mez I, Ruiz-Mart\u00ednez J, Bergareche A, Mart\u00ed-Mass\u00f3 JF, Mart\u00ednez-Lage P, Izagirre A, Rodr\u00edguez-Oroz MC (2017) Tau\/\u03b1-synuclein ratio and INfLammatory proteins in Parkinson\u2019s disease: an exploratory study. Mov Disord 32(7):1066\u20131073. https:\/\/doi.org\/10.1002\/mds.27001","journal-title":"Mov Disord"},{"issue":"1","key":"13546_CR96","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ene.14032","volume":"27","author":"MG F\u00f8rland","year":"2020","unstructured":"F\u00f8rland MG, Tysnes O-B, Aarsland D, Maple-Gr\u00f8dem J, Pedersen KF, Alves G, Lange J (2020) The value of cerebrospinal fluid \u03b1-synuclein and the tau\/\u03b1-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology. Eur J Neurol 27(1):43\u201350. https:\/\/doi.org\/10.1111\/ene.14032","journal-title":"Eur J Neurol"},{"issue":"3","key":"13546_CR97","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11481-019-09835-4","volume":"14","author":"S Manne","year":"2019","unstructured":"Manne S, Kondru N, Hepker M, Jin H, Anantharam V, Lewis M, Huang X, Kanthasamy A, Kanthasamy AG (2019) Ultrasensitive detection of aggregated \u03b1-synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the RT-QuIC assay: new high-throughput neuroimmune biomarker assay for Parkinsonian disorders. J Neuroimmune Pharmacol 14(3):423\u2013435. https:\/\/doi.org\/10.1007\/s11481-019-09835-4","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"13546_CR98","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD, Antelmi E, Mammana A, Hughson AG, Calandra-Buonaura G, Ladogana A, Plazzi G, Cortelli P, Caughey B, Parchi P (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140(1):49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"issue":"5","key":"13546_CR99","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ana.25447","volume":"85","author":"A van Rumund","year":"2019","unstructured":"van Rumund A, Green AJE, Fairfoul G, Esselink RAJ, Bloem BR, Verbeek MM (2019) \u03b1-synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism. Ann Neurol 85(5):777\u2013781. https:\/\/doi.org\/10.1002\/ana.25447","journal-title":"Ann Neurol"},{"issue":"6","key":"13546_CR100","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/acn3.772","volume":"6","author":"A Garrido","year":"2019","unstructured":"Garrido A, Fairfoul G, Tolosa ES, Mart\u00ed MJ, Green A, Barcelona LRRK2 Study Group (2019) \u03b1-Synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson\u2019s disease. Ann Clin Transl Neurol 6(6):1024\u20131032. https:\/\/doi.org\/10.1002\/acn3.772","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"13546_CR101","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14(1):38\u201348. https:\/\/doi.org\/10.1038\/nrn3406","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"13546_CR102","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41531-022-00431-7","volume":"8","author":"C Xiang","year":"2022","unstructured":"Xiang C, Cong S, Tan X, Ma S, Liu Y, Wang H, Cong S (2022) A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):165. https:\/\/doi.org\/10.1038\/s41531-022-00431-7","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"13546_CR103","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MTM, Parkkinen L, Green AJE (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3(10):812\u2013818. https:\/\/doi.org\/10.1002\/acn3.338","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"13546_CR104","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.25824","volume":"88","author":"W Singer","year":"2020","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Boeve BF, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Savica R, Suarez MD, Soto C, Low PA (2020) Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies. Ann Neurol 88(3):503\u2013512. https:\/\/doi.org\/10.1002\/ana.25824","journal-title":"Ann Neurol"},{"key":"13546_CR105","unstructured":"Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study\u2014ScienceDirect. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1474442224003958?via%3Dihub. Accessed 08 June 2025"},{"key":"13546_CR106","unstructured":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32025029\/. Accessed 03 Aug 2024"},{"issue":"6","key":"13546_CR107","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A der Van Perren","year":"2020","unstructured":"der Van Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W, den Van Haute C, Gentleman S, Melki R, Baekelandt V (2020) The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol 139(6):977\u20131000. https:\/\/doi.org\/10.1007\/s00401-020-02157-3","journal-title":"Acta Neuropathol"},{"issue":"4","key":"13546_CR108","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018309","volume":"9","author":"A Yuan","year":"2017","unstructured":"Yuan A, Rao MV, Veeranna N, Nixon RA (2017) Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol 9(4):a018309. https:\/\/doi.org\/10.1101\/cshperspect.a018309","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"13546_CR109","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1007\/s00415-024-12647-z","volume":"271","author":"S Katzdobler","year":"2024","unstructured":"Katzdobler S, N\u00fcbling G, Klietz M, Fietzek UM, Palleis C, Bernhardt AM, Wegner F, Huber M, Rogozinski S, Schneider L-S, Spruth EJ, Beyle A, Vogt IR, Brandt M, Hansen N, Glanz W, Brockmann K, Spottke A, Hoffmann DC, Peters O, Priller J, Wiltfang J, D\u00fczel E, Schneider A, Falkenburger B, Klockgether T, Gasser T, Nuscher B, Haass C, H\u00f6glinger G, Levin J (2024) GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA). J Neurol 271(10):6991\u20136999. https:\/\/doi.org\/10.1007\/s00415-024-12647-z","journal-title":"J Neurol"},{"issue":"9","key":"13546_CR110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075091","volume":"8","author":"J Gaiottino","year":"2013","unstructured":"Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU, Regeniter A, Lindberg RL, Kappos L, Leppert D, Petzold A, Giovannoni G, Kuhle J (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE 8(9):e75091. https:\/\/doi.org\/10.1371\/journal.pone.0075091","journal-title":"PLoS ONE"},{"issue":"2","key":"13546_CR111","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","volume":"16","author":"R Constantinescu","year":"2010","unstructured":"Constantinescu R, Rosengren L, Johnels B, Zetterberg H, Holmberg B (2010) Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Parkinsonism Relat Disord 16(2):142\u2013145. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.07.007","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"13546_CR112","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3233\/JAD-190615","volume":"72","author":"S-Y Wang","year":"2019","unstructured":"Wang S-Y, Chen W, Xu W, Li J-Q, Hou X-H, Ou Y-N, Yu J-T, Tan L (2019) Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis. J Alzheimers Dis 72(4):1353\u20131361. https:\/\/doi.org\/10.3233\/JAD-190615","journal-title":"J Alzheimers Dis"},{"key":"13546_CR113","unstructured":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/28179466\/. Accessed 03 Aug 2024"},{"issue":"7","key":"13546_CR114","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/mds.28101","volume":"35","author":"H Zetterberg","year":"2020","unstructured":"Zetterberg H (2020) Is there a value of neurofilament light as a biomarker for neurodegeneration in Parkinson\u2019s disease? Mov Disord 35(7):1111\u20131112. https:\/\/doi.org\/10.1002\/mds.28101","journal-title":"Mov Disord"},{"issue":"1","key":"13546_CR115","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1038\/s41467-023-42107-7","volume":"14","author":"AD Klein","year":"2023","unstructured":"Klein AD, Outeiro TF (2023) Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria. Nat Commun 14(1):6383. https:\/\/doi.org\/10.1038\/s41467-023-42107-7","journal-title":"Nat Commun"},{"issue":"15","key":"13546_CR116","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/mds.23287","volume":"25","author":"TJ Montine","year":"2010","unstructured":"Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J (2010) CSF A\u03b2(42) and tau in Parkinson\u2019s disease with cognitive impairment. Mov Disord 25(15):2682\u20132685. https:\/\/doi.org\/10.1002\/mds.23287","journal-title":"Mov Disord"},{"issue":"3","key":"13546_CR117","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.22311","volume":"69","author":"M Shi","year":"2011","unstructured":"Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69(3):570\u2013580. https:\/\/doi.org\/10.1002\/ana.22311","journal-title":"Ann Neurol"},{"issue":"10","key":"13546_CR118","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/jnnp.2009.199950","volume":"81","author":"G Alves","year":"2010","unstructured":"Alves G, Br\u00f8nnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes O-B, Larsen JP, Mulugeta E (2010) CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson\u2019s disease: The Norwegian ParkWest Study. J Neurol Neurosurg Psychiatry 81(10):1080\u20131086. https:\/\/doi.org\/10.1136\/jnnp.2009.199950","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"13546_CR119","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79386","volume":"17","author":"M Dasari","year":"2025","unstructured":"Dasari M, Medapati RV (2025) Cerebrospinal fluid biomarkers for diagnosis of parkinson\u2019s disease: a systematic review. Cureus 17(2):e79386. https:\/\/doi.org\/10.7759\/cureus.79386","journal-title":"Cureus"},{"issue":"3","key":"13546_CR120","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","volume":"21","author":"C Liu","year":"2015","unstructured":"Liu C, Cholerton B, Shi M, Ginghina C, Cain KC, Auinger P, Parkinson Study Group DATATOP Investigators, Zhang J (2015) CSF tau and tau\/A\u03b242 predict cognitive decline in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(3):271\u2013276. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.12.027","journal-title":"Parkinsonism Relat Disord"},{"key":"13546_CR121","doi-asserted-by":"publisher","unstructured":"L P, C L, L M, Y T, M H, X Y, G Z, Z Z, J X, G C, Z Z (2022) Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease. Brain J Neurol. https:\/\/doi.org\/10.1093\/brain\/awac171","DOI":"10.1093\/brain\/awac171"},{"key":"13546_CR122","doi-asserted-by":"publisher","unstructured":"Lin YM, Banoth D, Wali MH, Bekova K, Abdulla N, Gurugubelli S, Khan S (2024) The role of alpha-synuclein and tubulin-associated unit (Tau) proteins in the diagnosis, prognosis, and treatment of Parkinson\u2019s disease: a systematic review. Cureus 16(7):e64766. https:\/\/doi.org\/10.7759\/cureus.64766","DOI":"10.7759\/cureus.64766"},{"issue":"4","key":"13546_CR123","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3233\/JAD-201139","volume":"79","author":"A Mart\u00ednez-Maldonado","year":"2021","unstructured":"Mart\u00ednez-Maldonado A, Ontiveros-Torres M\u00c1, Harrington CR, Montiel-Sosa JF, Prandiz RG-T, Bocanegra-L\u00f3pez P, Sorsby-Vargas AM, Bravo-Mu\u00f1oz M, Flor\u00e1n-Gardu\u00f1o B, Villanueva-Fierro I, Perry G, Garc\u00e9s-Ram\u00edrez L, de la Cruz F, Mart\u00ednez-Robles S, Pacheco-Herrero M, Luna-Mu\u00f1oz J (2021) Molecular processing of tau protein in progressive supranuclear palsy: neuronal and glial degeneration. J Alzheimers Dis 79(4):1517\u20131531. https:\/\/doi.org\/10.3233\/JAD-201139","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"13546_CR124","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3233\/JAD-201548","volume":"80","author":"C Cong","year":"2021","unstructured":"Cong C, Zhang W, Qian X, Qiu W, Ma C (2021) Significant overlap of \u03b1-synuclein, amyloid-\u03b2, and phospho-tau pathologies in neuropathological diagnosis of Lewy-related pathology: evidence from China human brain bank. J Alzheimers Dis 80(1):447\u2013458. https:\/\/doi.org\/10.3233\/JAD-201548","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"13546_CR125","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz C, McMillan CT, Gelpi E, Compta Y, van Swieten JC, Laat LD, Troakes C, Al-Sarraj S, Robinson JL, Roeber S, Xie SX, Lee VM-Y, Trojanowski JQ, H\u00f6glinger GU (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140(2):99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2","journal-title":"Acta Neuropathol"},{"issue":"21","key":"13546_CR126","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","volume":"112","author":"J Xiang","year":"2024","unstructured":"Xiang J, Tang J, Kang F, Ye J, Cui Y, Zhang Z, Wang J, Wu S, Ye K (2024) Gut-induced alpha-synuclein and tau propagation initiate Parkinson\u2019s and Alzheimer\u2019s disease co-pathology and behavior impairments. Neuron 112(21):3585-3601.e5. https:\/\/doi.org\/10.1016\/j.neuron.2024.08.003","journal-title":"Neuron"},{"issue":"2","key":"13546_CR127","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, Iwasyk JE, Maghames CM, Meymand ES, Cox TO, Riddle DM, Zhang B, Trojanowski JQ, Lee VM-Y (2020) Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology. Neuron 105(2):260-275.e6. https:\/\/doi.org\/10.1016\/j.neuron.2019.10.010","journal-title":"Neuron"},{"issue":"2","key":"13546_CR128","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.01.001","volume":"105","author":"C Cook","year":"2020","unstructured":"Cook C, Petrucelli L (2020) A\u03b2 puts the alpha in synuclein. Neuron 105(2):205\u2013206. https:\/\/doi.org\/10.1016\/j.neuron.2020.01.001","journal-title":"Neuron"},{"issue":"11","key":"13546_CR129","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","volume":"69","author":"S Hall","year":"2012","unstructured":"Hall S, \u00d6hrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F, Nilsson C, Widner H, Decraemer H, N\u00e4gga K, Minthon L, Londos E, Vanmechelen E, Holmberg B, Zetterberg H, Blennow K, Hansson O (2012) Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or Parkinsonian disorders. Arch Neurol 69(11):1445\u20131452. https:\/\/doi.org\/10.1001\/archneurol.2012.1654","journal-title":"Arch Neurol"},{"issue":"8","key":"13546_CR130","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/cells11081261","volume":"11","author":"L Smith","year":"2022","unstructured":"Smith L, Schapira AHV (2022) GBA variants and Parkinson disease: mechanisms and treatments. Cells 11(8):1261. https:\/\/doi.org\/10.3390\/cells11081261","journal-title":"Cells"},{"issue":"11","key":"13546_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119605","volume":"24","author":"F Michetti","year":"2023","unstructured":"Michetti F, Clementi ME, Di Liddo R, Valeriani F, Ria F, Rende M, Di Sante G, Romano Spica V (2023) The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker. Int J Mol Sci 24(11):9605. https:\/\/doi.org\/10.3390\/ijms24119605","journal-title":"Int J Mol Sci"},{"key":"13546_CR132","unstructured":"Targeting S100\u03b2 protein as a surrogate biomarker and its role in various neurological disorders\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32727332\/. Accessed 03 Aug 2024"},{"key":"13546_CR133","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fnagi.2017.00308","volume":"9","author":"C-Y Xu","year":"2017","unstructured":"Xu C-Y, Kang W-Y, Chen Y-M, Jiang T-F, Zhang J, Zhang L-N, Ding J-Q, Liu J, Chen S-D (2017) DJ-1 inhibits \u03b1-synuclein aggregation by regulating chaperone-mediated autophagy. Front Aging Neurosci 9:308. https:\/\/doi.org\/10.3389\/fnagi.2017.00308","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"13546_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091377","volume":"8","author":"M Repici","year":"2019","unstructured":"Repici M, Giorgini F (2019) DJ-1 in Parkinson\u2019s Disease: Clinical Insights and Therapeutic Perspectives. J Clin Med 8(9):1377. https:\/\/doi.org\/10.3390\/jcm8091377","journal-title":"J Clin Med"},{"issue":"1","key":"13546_CR135","doi-asserted-by":"publisher","first-page":"16866","DOI":"10.1038\/s41598-018-35376-6","volume":"8","author":"J Youn","year":"2018","unstructured":"Youn J, Lee S-B, Lee HS, Yang HO, Park J, Kim JS, Oh E, Park S, Jang W (2018) Cerebrospinal fluid levels of autophagy-related proteins represent potentially novel biomarkers of early-stage Parkinson\u2019s disease. Sci Rep 8(1):16866. https:\/\/doi.org\/10.1038\/s41598-018-35376-6","journal-title":"Sci Rep"},{"issue":"8","key":"13546_CR136","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1172\/JCI45803","volume":"121","author":"DS Goldstein","year":"2011","unstructured":"Goldstein DS, Holmes C, Kopin IJ, Sharabi Y (2011) Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases. J Clin Invest 121(8):3320\u20133330. https:\/\/doi.org\/10.1172\/JCI45803","journal-title":"J Clin Invest"},{"issue":"6","key":"13546_CR137","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/aws055","volume":"135","author":"DS Goldstein","year":"2012","unstructured":"Goldstein DS, Holmes C, Sharabi Y (2012) Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson\u2019s disease and other synucleinopathies. Brain 135(6):1900\u20131913. https:\/\/doi.org\/10.1093\/brain\/aws055","journal-title":"Brain"},{"issue":"25","key":"13546_CR138","doi-asserted-by":"publisher","first-page":"17455","DOI":"10.18632\/oncotarget.24736","volume":"9","author":"MCT Dos Santos","year":"2018","unstructured":"Dos Santos MCT, Barreto-Sanz MA, Correia BRS, Bell R, Widnall C, Perez LT, Berteau C, Schulte C, Scheller D, Berg D, Maetzler W, Galante PAF, da Nogueira Costa A (2018) miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson\u2019s disease. Oncotarget 9(25):17455\u201317465. https:\/\/doi.org\/10.18632\/oncotarget.24736","journal-title":"Oncotarget"},{"issue":"3","key":"13546_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2025.100204","volume":"13","author":"Y Yin","year":"2025","unstructured":"Yin Y, Su D, Lam JST, Feng T (2025) Advances in clinical neurorestorative treatments of Parkinson\u2019s disease. J Neurorestor 13(3):100204. https:\/\/doi.org\/10.1016\/j.jnrt.2025.100204","journal-title":"J Neurorestor"},{"issue":"2","key":"13546_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2023.100054","volume":"11","author":"H Huang","year":"2023","unstructured":"Huang H, Bach JR, Sharma HS, Saberi H, Jeon SR, Guo X, Shetty A, Hawamdeh Z, Sharma A, Wild K, Siniscalco D, Sanberg PR, Hu Y, Xue M, Chen L, Han F, Otom A, Hu J, Zhang Q (2023) The 2022 yearbook of neurorestoratology. J Neurorestoratol 11(2):100054. https:\/\/doi.org\/10.1016\/j.jnrt.2023.100054","journal-title":"J Neurorestoratol"},{"issue":"3","key":"13546_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2024.100136","volume":"12","author":"H Huang","year":"2024","unstructured":"Huang H, Bach JR, Sharma HS, Chen L, Wu P, Sarnowska A, Otom A, Xue M, Saberi H, He X, Alhawamdeh Z, Kuffler D, Hu J, Siniscalco D, Alvarez EO, Li M, Sanberg PR (2024) The 2023 yearbook of neurorestoratology. J Neurorestor 12(3):100136. https:\/\/doi.org\/10.1016\/j.jnrt.2024.100136","journal-title":"J Neurorestor"},{"issue":"10","key":"13546_CR142","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/mds.27794","volume":"34","author":"K Tsukita","year":"2019","unstructured":"Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R (2019) Value of in vivo \u03b1-synuclein deposits in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 34(10):1452\u20131463. https:\/\/doi.org\/10.1002\/mds.27794","journal-title":"Mov Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13546-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:29:23Z","timestamp":1765812563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13546-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":142,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["13546"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13546-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"793"}}